2023 ERS Congress

Pulmonary rehabilitation offers no benefit in outcomes for patients already undergoing bronchoscopic lung volume reduction using endobronchial valves.

A new risk stratification approach allows physicians to estimate 1-year mortality for newly diagnosed patients with pulmonary arterial hypertension based on cardiac MRI.

Cooperation between local hospitals and specialized centers leads to better care for patients with pulmonary fibrosis, is less environmentally damaging.

COPD patients with ECG abnormalities are at greater risk of exacerbations, cardiovascular problems, and death. Triple therapy with fluticasone, umeclidinium, and vilanterol appears beneficial.

A stop-smoking intervention, offered in combination with a lung cancer screening program, is proving successful in encouraging people to quit smoking.

Results from the Australian Barwon Infant Study show children who have a more mature gastrointestinal microbiome at age 1 are less likely to suffer from atopic wheeze at age 4.

COPD patients who are automatically administered oxygen during hospitalization for exacerbation spend more time in normoxemia than patients in whom oxygen delivery is manually regulated.

Up to a third of patients with severe eosinophilic asthma who do not achieve clinical remission after 1 year of treatment with benralizumab still achieve remission in the second year.

A deep neural network has been developed to distinguish between patients with and without asthma through breath test measurement data.

Sputum colour in patients with bronchiectasis could be considered a simple biomarker, providing information about long-term prognosis.

Idiopathic Pulmonary Fibrosis (IPF) is a chronic life-threatening fibrosing interstitial pneumonia of unknown cause [ 1 ]. Despite recently established anti-fibrotic treatment IPF prognosis is one of the worst among interstitial lung diseases …

Kristen Rat Sarcoma viral oncogene (KRAS) mutations are one of the most common oncogenic drivers found in 12–14% of non-small cell lung cancer (NSCLC) and 4% of colorectal cancer tumors. Although previously difficult to target, sotorasib and …

Streptococcus pneumoniae is the leading cause of bacterial pneumonia and global mortality in children [ 2 – 5 ]. In 2016, S. pneumoniae has been estimated to account for approximately 197 million cases of pneumonia and 1.1 million deaths [ 6 ].